Paclitaxel - PDFSEARCH.IO - Document Search Engine

Paclitaxel
Results: 309

#	Item
1	CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Model-Based Meta-Analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Authors D Lu, A Joshi, H Li, N Zhang, MM Ren, Y Gao, R Wada and JY Jin Add to Reading List Source URL: www.excelra.com Language: English - Date: 2018-07-26 07:12:46
2	2013 年 Ⅰ．原著論文 1) Yamada K, Tanabe H, Imai M, Jobo T, Kudo K, Fujiwara H, Nagata C, Furuya K, Suzuki M, Ochiai K, Tanaka T, Yasuda M. Feasibility study of paclitaxel plus Add to Reading List Source URL: jikei-obgyn.jp Language: English - Date: 2014-11-13 21:35:25
3	Final Results of a Phase 1b of Tarextumab (OMP-59R5) (anti-Notch2/3 antibody) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Stu Add to Reading List Source URL: s3.amazonaws.com - Date: 2014-09-25 16:16:37
4	Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Colin Weekes,1 Add to Reading List Source URL: publications.oncomed.com - Date: 2016-10-09 05:13:10
5	Preclinical and Clinical Activity of Anti-DLL4 (Demcizumab) in Combination with Gemcitabine Plus nab-Paclitaxel in Pancreatic Cancer Manuel Hidalgo, Antonio Cubillo, Robert Stagg, Jakob Dupont, Wan-Ching Yen, Tim Add to Reading List Source URL: s3.amazonaws.com - Date: 2014-11-19 14:29:44**
6	A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer Dose Level – mg/kg Median age (years) Add to Reading List Source URL: posters.omed.s3.amazonaws.com - Date: 2016-01-22 10:42:40
7	Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Wells Messersmith,1 Add to Reading List Source URL: publications.oncomed.com - Date: 2016-10-08 04:07:44
8	A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer 1Hidalgo Patient Demographics (n=47) DEM + GEM Add to Reading List Source URL: s3.amazonaws.com - Date: 2014-09-25 16:14:56
9	Final Results of a Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Study E Add to Reading List Source URL: s3.amazonaws.com - Date: 2015-01-16 14:31:43
10	Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in patients (pts) with recurrent platinum-sensitive ovarian cancer (OC) Roisin O’Cearbhaill1, Scott McM Add to Reading List Source URL: s3.amazonaws.com - Date: 2016-06-05 05:57:06

UPDATE